wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33422258-1F714E9F-D671-4830-8FB7-448C5A6DAB2B
Q33422258-1F714E9F-D671-4830-8FB7-448C5A6DAB2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422258-1F714E9F-D671-4830-8FB7-448C5A6DAB2B
Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.
P2860
Q33422258-1F714E9F-D671-4830-8FB7-448C5A6DAB2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422258-1F714E9F-D671-4830-8FB7-448C5A6DAB2B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
27b269ef3ab22a069302766eacd99fb1ffaa42c5
P2860
Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199).